All News

Engelhardt lands stem cell transplant research grant

Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure.

Transplant society honors Helderman’s contributions

More than three decades ago, J. Harold Helderman, M.D., medical director of the Vanderbilt Transplant Center, joined a handful of colleagues from across the country to create a society for transplant physicians.

Faculty meeting highlights VUSM achievements

Despite a challenging health care landscape, Vanderbilt University Medical Center continues to advance the highest-quality patient care, train the next generation of physician leaders and push forward the frontiers of biomedical science.

Health literacy added to transplant outcomes survey

A Vanderbilt University Medical Center postdoctoral research fellow in the area of transplant outcomes research has added health literacy as a metric to an existing battery of surveys that assess patient-reported outcomes in Vanderbilt transplant patients.

Study links stem cell gene to prostate cancer susceptibility

A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found.

Altruistic donor chain enhances transplant options

Thanks to a series of altruistic donations that began in Colorado, three people who were waiting for a kidney received a life-saving transplant, including a patient at Vanderbilt University Medical Center.

1 88 89 90 91 92 99